CAB-LA: the prevention jab that never had its moment, and what it leaves behind as LEN arrives
The two-monthly HIV prevention injection was approved over three years ago but never reached government clinics. As LEN prepares to launch, CAB-LA’s quiet exit carries lessons about what it takes to turn good science into public health
Black News 
The two-monthly HIV prevention injection was approved over three years ago but never reached government clinics. As LEN prepares to launch, CAB-LA’s quiet exit carries lessons about what it takes to turn good science into public health
